After 10 years of development and testing, Charlottesville’s BrightSpec Inc. is ready to commercialize a cutting-edge scientific instrument. To that end, the company recently closed an $18.4 million Series C round.
The round was led by San Francisco’s Genoa Ventures and Ann Arbor, Michigan’s Arboretum Ventures and included participation from existing investors Medvest Capital of Birmingham, Alabama, Charlottesville’s Felton Group LLC and the UVA Seed Fund.
BrightSpec produces molecular…
